Alzheimer’s disease is the most common form of dementia, but different types of dementia develop based on changes in the brain and underlying health problems. Dr. Mark B. Randolph at Juventas in San Marcos, Texas, encourages those with memory loss and other symptoms of dementia to schedule a consultation to learn how treatment with plasma therapy may help improve cognitive function.
Dementia isn’t a disease: It refers to a group of symptoms that affect thinking and memory severely enough to interfere with normal, daily functioning. Some types of dementia are caused by underlying health conditions, but the types that are primarily brain disorders include:
While all types of dementia cause loss of memory, memory loss alone doesn’t mean you have dementia. These additional symptoms are commonly seen in dementia:
Cognitive: Memory loss, confusion, uncoordinated motor function, and difficulty communicating, problem-solving, handling complex tasks, planning and organizing
Psychological: Depression, anxiety, personality changes, inappropriate behavior, agitation, paranoia, hallucinations
Alzheimer’s disease is the most common cause of dementia, and the sixth leading cause of death in the United States. Alzheimer’s is caused by amyloid plaques and neurofibrillary tangles that build-up in the brain and destroy neurons. These structures appear in the brain long before symptoms appear, then the disease slowly progresses as they accumulate. Alzheimer’s symptoms usually occur once people reach their mid-60’s.
Plasma therapy is a medical procedure in which plasma from a young donor (between the ages of 18-25) is infused into a patient with Alzheimer’s. The procedure can help those with Alzheimer’s by adding factors found within young plasma that are missing from old plasma, therefore reversing some of the effects found in Alzheimer’s.
A study published in the Journal of Alzheimer’s Disease in January 2017 found that plasma therapy using 5% albumin improved symptoms in a group of adults with Alzheimer’s disease.
Forty-two study participants were divided into control and treatment groups. The treatment group was further divided into three groups that received plasma therapy over either three, six or 12 weeks. Six months after treatment ended, the patients were evaluated.
The researchers concluded that plasma therapy with young 5% albumin modified levels of amyloid-beta in cerebrospinal fluid and plasma. Those treated with plasma showed improvement in memory and language functions.
Alzheimer’s is a complex disease and the results of plasma therapy differ for each person. Please don’t hesitate to contact the staff at Juventas to learn more about the benefits of plasma therapy.